Clinical Trial Update: Teicoplanin Prophylaxis for Total Hip or Knee Arthroplasty [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating teicoplanin as prophylaxis for infections in patients undergoing total hip or knee arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee
• Prosthetic Joint Infection

Drugs mentioned

• Teicoplanin (Teicoplanin)

Snippet

Sponsor: University of Athens | Conditions: Total Hip and Knee Arthroplasties | Phase 4 | Status: COMPLETED